Naruhiko Ishiwada

Dr. Naruhiko Ishiwada

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Vaccine
Verified
Journal Article
Closed access
SSShigeru Suga
Shigeru Suga
NINaruhiko Ishiwada
Naruhiko Ishiwada
YSYuko Sasaki
Yuko Sasaki
HAHideki Akeda
Hideki Akeda
JNJunichiro Nishi
Junichiro Nishi
KSKeigo Shibayama
Keigo Shibayama

1 January 2005 in Circulation Journal
Verified
Journal Article
Closed access
PDF file
NINaruhiko Ishiwada
Naruhiko Ishiwada
KNKoichiro Niwa
Koichiro Niwa
STShigeru Tateno
Shigeru Tateno
MYMasao Yoshinaga
Masao Yoshinaga
MTMasaru Terai
Masaru Terai
DPDiagnosis Cardiac Surgery Joint Working Groups For Guidelines For Prophylaxis
Diagnosis Cardiac Surgery Joint Working Groups For Guidelines For Prophylaxis
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 September 2014 in Vaccine
Verified
Journal Article
Closed access
NINaruhiko Ishiwada
Naruhiko Ishiwada
HHHaruka Hishiki
Haruka Hishiki
KNKoo Nagasawa
Koo Nagasawa
SNSachiko Naito
Sachiko Naito
YSYasunori Sato
Yasunori Sato
KSKeigo Shibayama
Keigo Shibayama

1 December 2016 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
NINaruhiko Ishiwada
Naruhiko Ishiwada
MWMasaharu Watanabe
Masaharu Watanabe
SMShota Murata
Shota Murata
NTNoriko Takeuchi
Noriko Takeuchi
TTToshibumi Taniguchi
Toshibumi Taniguchi
HIHidetoshi Igari
Hidetoshi Igari

17 April 2020 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
NTN. Takeuchi
N. Takeuchi
SNS. Naito
S. Naito
MOM. Ohkusu
M. Ohkusu
KAK. Abe
K. Abe
KSK. Shizuno
K. Shizuno
NINaruhiko Ishiwada
Naruhiko Ishiwada
Studies on community-acquired pneumonia (CAP) and pneumococcal pneumonia (PP) related to the 13-valent pneumococcal conjugate vaccine (PCV13) introduction in Asia are scarce. This study aimed to investigate the epidemiological and microbiological determinants of hospitalised CAP and PP after PCV13 was introduced in Japan. This observational hospital-based surveillance study included children aged ⩽15 years, admitted to hospitals in and around Chiba City, Japan. Participants had bacterial pneumonia based on a positive blood or sputum culture for bacterial pathogens. Serotype and antibiotic-susceptibility testing of Streptococcus pneumoniae and Haemophilus influenzae isolates from patients with bacterial pneumonia were assessed. The CAP hospitalisation rate per 1000 child-years was 17.7, 14.3 and 9.7 in children aged <5 years and 1.18, 2.64 and 0.69 in children aged 5–15 years in 2008, 2012 and 2018, respectively. There was a 45% and 41% reduction in CAP hospitalisation rates, between the pre-PCV7 and PCV13 periods, respectively. Significant reductions occurred in the proportion of CAP due to PP and PCV13 serotypes. Conversely, no change occurred in the proportion of CAP caused by H. influenzae. The incidence of hospitalised CAP in children aged ⩽15 years was significantly reduced after the introduction of PCV13 in Japan. Continuous surveillance is necessary to detect emerging PP serotypes.

7 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YYYuriko Yamazaki
Yuriko Yamazaki
TITomoka Ito
Tomoka Ito
SNSeitaro Nakagawa
Seitaro Nakagawa
TSTakashi Sugihira
Takashi Sugihira
CKChinami Kurita-Tachibana
Chinami Kurita-Tachibana
YNYumi Nakamura
Yumi Nakamura
Staphylococcus aureus can cause outbreaks and becomes multi-drug resistant through gene mutations and acquiring resistance genes. However, why S. aureus easily adapts to hospital environments, promoting resistance and recurrent infections, remains unknown. Here we show that a specific S. aureus lineage evolved from a clone that expresses the accessory gene regulator (Agr) system to subclones that reversibly suppressed Agr and caused an outbreak in the hospital setting. S. aureus with flexible Agr regulation shows increased ability to acquire antibiotic-resistant plasmids, escape host immunity, and colonize mice. Bacteria with flexible Agr regulation shows altered cytosine genomic methylation, including the decreased 5mC methylation in transcriptional regulator genes (pcrA and rpsD), compared to strains with normal Agr expression patterns. In this work, we discover how altered genomic methylation promotes flexible Agr regulation which is associated with persistent pathogen colonization in the hospital environment.